Hi all,
Long time holder of RAP, first time poster.
Been busy with life over the past year or so, so I haven't had a chance to follow RAP as closely as I used to. Can someone please let me know what the plan is for the adult American trials? Seeing as we can only run the trial through the northern hemisphere winter (once a year), it would make sense to try get this done ASAP... right?
Regards,
D
- Forums
- ASX - By Stock
- RAP
- Ann: ResAppDx-EU for Adult Respiratory Disease Receives CE Mark
Ann: ResAppDx-EU for Adult Respiratory Disease Receives CE Mark, page-42
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
- There are more pages in this discussion • 99 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)